Senior insider sale
Chief Scientific Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$994.4K
26.52K shares
What this filing means
BETZ STEPHEN F. plans to sell 26.52K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $994.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001628280-26-017947
Officer· Chief Scientific Officer
Since Oct 2021
26.52K
Shares to sell
$994.4K
Approx. market value
26.52K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
3/15/2026
26.52KTotal acquired26.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2026 | Restricted Stock Unit Vesting Compensation | 26.52K | — |
| Total | 26.52K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
26.52K
Market value
$994.4K
3/16/2026
Total
Units
26.52K
Value
$994.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/16/2026 | 26.52K | $994.4K | Nasdaq | Planned |
| Total | 26.52K | $994.4K | ||